Venevolenskaia L I, Finogenova S A, Alekseeva L I, Erdes Sh, Iakovleva D B, Krylov M Iu
Genetika. 1991 Feb;27(2):335-44.
The study on the nature of distribution of certain mendelian markers aimed at specifying their role in determination of rheumatoid arthritis disease was carried out, based on the material from the Family Data Bank of the Department of Epidemiology and Genetics of the rheumatic diseases in this institute comprising data on 200 families of patients with definite rheumatoid arthritis (RA). Antigens of HLA-system (the loci A, B, DR), ABO blood groups, Rh, MN and P, phenotypes of acid erythrocyte phosphatase and the types of haptoglobin were studied. Based on the data from this and the previous studies, it is established that the steadiest deviations of the RA patients groups from the general population concerned the frequency of HLA A11, B12, B27 and DR4, blood group P and phenotypes of the acid erythrocyte phosphatase. When using additional controls--a group of healthy mothers of women-probands from the families with the type of marriage "healthy x healthy", and analysing some pair combinations of the HLA system antigens, it was demonstrated that the most clearly their role in formation of the disease display the antigens DR4, and in their absence--DR3, and B12, whereas accumulation of A11 and B27 depended on the presence of other antigens of HLA loci--A and B. Taken together, these data may imply that genetic markers under study serve, when in certain combinations, as "modifiers" of the major gene, or, in a general case, of major genes of multifactorial disease affecting its appearance and clinical manifestations.
基于该研究所风湿性疾病流行病学与遗传学系家庭数据库中的资料,开展了一项关于某些孟德尔标记物分布性质的研究,以明确它们在类风湿性关节炎疾病判定中的作用。该数据库包含了200个确诊为类风湿性关节炎(RA)患者家庭的数据。研究了HLA系统的抗原(A、B、DR位点)、ABO血型、Rh、MN和P、酸性红细胞磷酸酶表型以及触珠蛋白类型。根据本次及以往研究的数据,已确定RA患者组与普通人群最稳定的偏差涉及HLA A11、B12、B27和DR4的频率、P血型以及酸性红细胞磷酸酶表型。当使用额外的对照——来自“健康×健康”婚姻类型家庭的女性先证者的健康母亲组,并分析HLA系统抗原的一些配对组合时,结果表明,在疾病形成中作用最明显的抗原是DR4,若不存在DR4,则是DR3和B12,而A11和B27的积累取决于HLA位点A和B的其他抗原的存在。综上所述,这些数据可能意味着,所研究的遗传标记物在某些组合中可作为主要基因的“修饰因子”,或者在一般情况下,作为影响多因素疾病外观和临床表现的主要基因的“修饰因子”。